
This book is the first to focus on Bayesian phase I-II clinical trials. It describes many problems with the conventional phase I-phase II paradigm and covers a large number of modern Bayesian phase I-II clinical trial designs.
Nous publions uniquement les avis qui respectent les conditions requises. Consultez nos conditions pour les avis.